Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06870591 · ClinicalTrials.gov registry record
Pivotal Study for the Cardiac Performance System (CPS)
A clinical trial of Cardiovascular Diseases, sponsored by Sensydia Corporation.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 10
- Study locations
NCT06870591: Recruiting study of Cardiovascular Diseases, sponsored by Sensydia Corporation.
NCT06870591 is a study of Cardiovascular Diseases that is actively recruiting participants, run by Sensydia Corporation. The registered enrollment target is 1,000 participants, below the 26,971-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (96% lower). The trial reports 10 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06870591, a study of Cardiovascular Diseases, is actively recruiting participants, sponsored by Sensydia Corporation.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 10
- Study locations
Study Summary
This multi-center, observational study evaluates the accuracy of the Cardiac Performance System (CPS), a non-invasive device, for measuring hemodynamic parameters in adult patients undergoing clinically indicated right heart catheterization. The study compares CPS measurements to invasive measurements to assess agreement and potential clinical utility.
Primary Outcome
Cardiac function metric measurement including Pulmonary Pressure measured in mmHg
Conditions Studied
Interventions
- DEVICE Cardiac Performance System (CPS)
Study Locations (10)
New Jersey
- Hackensack University Medical Center - Hackensack
- Jersey Shore University Medical Center - Neptune City
Alabama
- Huntsville Hospital Heart Center - Huntsville
Illinois
- Endeavor Health - Evanston
New York
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital - New York
Ohio
- The Ohio State University Medical Center - Columbus
Pennsylvania
- University of Pennsylvania - Penn Presbyterian Medical Center - Philadelphia
South Carolina
- Medical University of South Carolina - Charleston
Tennessee
- The Stern Cardiovascular Foundation, Inc. / Baptist Memorial Hospital - Germantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-04-22 |
| Est. Completion | 2026-05-30 |
What NCT06870591 shows while recruiting
NCT06870591 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 26,971-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Cardiac Performance System (CPS) is the first listed.
NCT06870591 lists 10 locations in 9 states (New Jersey, Alabama, Illinois).
Frequently Asked Questions
What is clinical trial NCT06870591 about?
NCT06870591 is a clinical study titled "Pivotal Study for the Cardiac Performance System (CPS)". This multi-center, observational study evaluates the accuracy of the Cardiac Performance System (CPS), a non-invasive device, for measuring hemodynamic parameters in adult patients undergoing clinically indicated right heart catheterization. The study compares CPS measurements to invasive measuremen...
What is the current status of trial NCT06870591?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-04-22. Estimated completion is 2026-05-30.
What conditions does trial NCT06870591 study?
This clinical trial studies the following conditions: Cardiovascular Diseases.
What interventions are being tested in trial NCT06870591?
The interventions under investigation include: Cardiac Performance System (CPS) (DEVICE).
Who is sponsoring clinical trial NCT06870591?
This trial is sponsored by Sensydia Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06870591 being conducted?
This trial has 10 study locations across Alabama, Illinois, New Jersey, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06870591's enrollment target sits among peer trials
1,000 48th of 300 higher than 244 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI